Breast Cancer Clinical Trial
Official title:
Medical Ericksonian Hypnosis on Patients Treated With Adjuvant Chemotherapy for Breast Cancer at the ICM Val d'Aurelle - Montpellier: a Feasibility Study
The main objective is to assess the feasibility of an intervention based on medical Ericksonian hypnosis as a complementary therapy in patients treated with surgery after a diagnosis of breast cancer, followed by an indication of adjuvant chemotherapy and radiotherapy
In the field of management of cancer, many approaches have been used since tens of years,
particularly in regard of pain management, both in achieving surgical or invasive procedures
in the pain induced by the disease itself. the investigators owe the first description in
1829 Chapelin and col who used hypnosis in a patient with breast cancer in which a mastectomy
should be performed. Meta-analysis (2000) showed the positive impact of analgesia obtained
through hypnosis on the perception of pain intensity. In children in whom regular venous
punctures is performed, using hypnosis seems indisputable on the management of anticipatory
anxiety, leading to a better experience of the act itself. Regarding the nausea and vomiting
induced by chemotherapy, numerous studies are old, not always randomized and performed often
before the era of the setrons; but seems favorable impact on anticipated nausea and vomiting,
the updated studies should emerge on the issue of delayed emesis which remain a serious
adverse event and not completely resolved. Mark to improve the EORTC validated tools of
quality of life measurement widely used for example in ovarian cancer.
The impact of hypnosis on the quality of life or the side effects of treatment or
rehospitalization for toxicity remains controversial (Judson, 2011). A meta-analysis
combining the tests carried out before and after the era of setrons (Richardson, 2007)
concluded that the effectiveness of the anticipated nausea and vomiting.
In this context,the investigators proposed to conduct a feasibility study to evaluate the
role and impact of medical Ericksonian hypnosis on acute and delayed adverse event (incl
nausea and vomiting) in female patients treated by adjuvant chemotherapy for breast cancer.
The main objective is to assess the feasibility of an intervention based on medical
Ericksonian hypnosis as a complementary therapy in patients treated with surgery after a
diagnosis of breast cancer, followed by an indication of adjuvant chemotherapy and
radiotherapy
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04681911 -
Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer
|
Phase 2 | |
Completed |
NCT04890327 -
Web-based Family History Tool
|
N/A | |
Terminated |
NCT04066790 -
Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer
|
Phase 2 | |
Completed |
NCT03591848 -
Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility
|
N/A | |
Recruiting |
NCT03954197 -
Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients
|
N/A | |
Terminated |
NCT02202746 -
A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer
|
Phase 2 | |
Active, not recruiting |
NCT01472094 -
The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
|
||
Recruiting |
NCT06049446 -
Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
|
||
Recruiting |
NCT06057636 -
Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study
|
N/A | |
Recruiting |
NCT05560334 -
A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations
|
Phase 2 | |
Active, not recruiting |
NCT05501769 -
ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer
|
Phase 1 | |
Recruiting |
NCT04631835 -
Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer
|
Phase 1 | |
Completed |
NCT04307407 -
Exercise in Breast Cancer Survivors
|
N/A | |
Recruiting |
NCT03544762 -
Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation
|
Phase 3 | |
Terminated |
NCT02482389 -
Study of Preoperative Boost Radiotherapy
|
N/A | |
Enrolling by invitation |
NCT00068003 -
Harvesting Cells for Experimental Cancer Treatments
|
||
Completed |
NCT00226967 -
Stress, Diurnal Cortisol, and Breast Cancer Survival
|
||
Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
Recruiting |
NCT06019325 -
Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy
|
N/A | |
Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 |